News Briefing channel feed

Am­gen en­lists En­tera in a drug dis­cov­ery pact; Boehringer brings out the bud­get ax

7 years ago

Shang­hai Jun­shi Bio­sciences next to test HKEX list­ing; With one eye on Sage, Mar­i­nus re­ports pre­lim PPD da­ta

7 years ago

Sanofi will elim­i­nate 670 jobs in France; Mod­er­na gets FDA or­phan sta­tus for pre­clin­i­cal as­set

7 years ago

Mallinck­rodt to spin off gener­ics busi­ness; Be­yond­Spring ready to sub­mit ap­proval for lead drug in Chi­na

7 years ago

UK sets up vac­cines cen­tre as Brex­it looms; Shang­hai's Elpi­science bags $35M in Se­ries B

7 years ago

Gilead­'s HIV drug De­scovy wins Chi­na's en­dorse­ment; Re­vance in­vestors smile as frown lines drug suc­ceeds piv­otal stud­ies

7 years ago

GAO pokes holes in FDA's or­phan des­ig­na­tion process; Take­da Tra­di­tion­al­ists make one more ap­peal against Shire buy­out ahead of vote

7 years ago

Boehringer ax­es biosim­i­lar de­vel­op­ment out­side US; Macro­Gen­ics, Chi­na's Zai Labs join forces to de­vel­op I/O treat­ments

7 years ago

In­cyte hires Janssen ex­ec as CSO Hu­ber moves to Third Rock; Syn­thorx set terms for $100M IPO

7 years ago

BeiGene inks $60M li­cens­ing, re­search pacts with Zymeworks; Mer­ck, Ab­b­Vie, Am­gen back neu­ro up­start

7 years ago

GW Phar­ma shares surge on pos­i­tive PhI­II fol­lowup; Il­lu­mi­na leads $18M round for Stil­la's DNA tech

7 years ago

Roivant joins forces with Ko­re­a's iN­tRON Bio to fight su­per­bugs; Evotec inks deal to lever­age AI to de­vel­op drugs

7 years ago

Eli Lil­ly vet takes helm at Brick­ell Biotech; Stem­line's El­zon­ris se­cures speedy EU re­view

7 years ago

Fortress Biotech sells bro­ker­age firm fol­low­ing Reuters ex­posé; Tra­con con­tends with an­oth­er set­back in brain can­cer

7 years ago

Take­da fam­i­ly preps for a last-stand vote against Shire buy­out; Eli Lil­ly re­port­ed­ly shop­ping drug port­fo­lio in Chi­na

7 years ago

Cen­trex­ion de­lays IPO; Ex­elix­is makes $40M as Cabome­tyx wins EU nod

7 years ago

Pfiz­er los­es key Lyri­ca patent bat­tle in the UK; Kleo Phar­ma clos­es $21M Se­ries B round

7 years ago

Roche wins speedy FDA re­view for Tecen­triq; South Ko­re­an au­thor­i­ties to look in­to Sam­sung Bi­o­Log­ics ac­count­ing prac­tices

7 years ago

Or­biMed leads $70M raise for Har­poon Ther­a­peu­tics; Zio­pharm inks com­bo deal with Re­gen­eron's PD-1

7 years ago

Bio­Marin looks for fast ap­proval of he­mo­phil­ia A gene ther­a­py; In­ves­ti­ga­tors tout En­ta­sis an­tibi­ot­ic

7 years ago

Shares of Bone Ther­a­peu­tics dive on PhI­II cell ther­a­py fail­ure; GSK-backed Sit­ryx inks dis­cov­ery deal

7 years ago

Am­gen of­fers cash and mile­stones for Proven­tion to take the lead on a celi­ac drug; Aveo's PhI­II fails to im­press, shares slide

7 years ago

Re­genxbio scores $180M vec­tor deal; Bris­tol-My­ers ex­pands agree­ment to test Op­di­vo with In­fin­i­ty's IPI-549

7 years ago

Ky­owa Hakko Kirin gears up to test IDO/PD-1 com­bo; Ab­b­Vie fights Hu­mi­ra biosim­i­lars with 80% price cut in Eu­rope

7 years ago
First page Previous page 54555657585960 Next page Last page
A service from the Financial Times